Infant Bacterial Therapeutics AB (9IB) Revenue

4 Followers

Infant Bacterial Therapeutics AB Revenue

Infant Bacterial Therapeutics AB had a revenue of 0.00 in the quarter ending Jun 30, 2026, with ―. This bring the company's revenue in the last twelve months to 0.00, Decreased ―. In the fiscal year ending Dec 31, 2025, Infant Bacterial Therapeutics AB had annual revenue of 0.00 with -100.00% growth.

Revenue (ttm)

0.00

Revenue Growth

―

P/S Ratio

―

Revenue/Employee

€0

Employees

Market Cap

€77.59M

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	―	-4.00K	-100.00%
Dec 31, 2024	4.00K	-73.00K	-94.81%
Dec 31, 2023	77.00K	65.00K	+541.67%
Dec 31, 2022	12.00K	―	+∞%
Dec 31, 2021	―	―	―
Dec 31, 2020	―	―	―
Dec 31, 2019	―	―	―
Dec 31, 2018	―	-238.00K	-100.00%
Dec 31, 2017	238.00K	―	―